相关实验视频
Updated: Jul 12, 2025

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
23.5K
重新评估血清 ангиотензин转化酶在沙尔科毒症中的作用
Shi-Yue Zheng1, Xin Du1, Jian-Zeng Dong1,2
1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Frontiers in immunology
|October 23, 2023
概括
Sarcoidosis 是一种全身性炎症性疾病. 由于颗粒瘤的表达,血清中血管酶转化酶 (ACE) 水平升高,有助于诊断类菌病并评估治疗的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 遗传学 是一个遗传学.
背景情况:
- 沙丘病是一个多系统性炎症性疾病,原因不明,主要影响肺和淋巴结.
- 疾病的呈现,发病率和流行率在全球范围内各不相同.
- 诊断依赖于临床发现,成像,生物标志物,以及活检上的特征性非化颗粒瘤.
研究的目的:
- 要突出血管酶转化酶 (ACE) 在沙尔科毒症中的作用.
- 解释ACE的功能和遗传多态性.
- 为了确定血清ACE作为一种主要的诊断和预后生物标志物,用于萨尔科毒症.
主要方法:
- 审查关于沙尔科毒症病原和生物标志物的现有文献.
- 分析血管氨转化酶 (ACE) 在氨-血管氨-氨系统中的作用.
- 检查萨尔科伊德颗粒瘤中的ACE表达及其与血清ACE水平的相关性.
主要成果:
- 血清 ангиотензин转化酶 (ACE) 水平在类病患者中升高.
- 在类粒瘤中的上皮质和巨细胞表达ACE.
- 血清ACE的增加是诊断沙尔科毒症的关键生物标志物.
结论:
- 血清ACE是一种有价值的生物标志物,用于诊断沙尔科毒症.
- 监测血清ACE水平可以帮助评估治疗疗效和患者预后.
- ACE遗传多态可能会影响疾病的发展.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
674
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
674
Antihypertensive Drugs: Direct Renin Inhibitors
650
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
650
Nephrotic Syndrome II : Assessment and Medical Management
8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
37
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
37
Antihypertensive Drugs: Angiotensin II Receptor Blockers
752
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
752

